Based on its share price, down 75% in the last three years, it's easy to write off Moderna (NASDAQ: MRNA) as a biotech ...

Shares of Moderna (NASDAQ: MRNA) zoomed as much as 33.3% higher this week, according to data from S&P Global Market ...

Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in ...

TikToker Magda, who goes by @magdacious on TikTok, posted a viral video announcing a new series she plans on creating: ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

In a move to bolster global health cooperation, China has pledged its unwavering support for the World Health Organization ...